Health and Human Services Secretary Robert F. Kennedy Jr. is cancelling 22 mRNA vaccine contracts funded by BARDA. Without evidence, Kennedy claimed these vaccines fail to protect effectively against ...

Arbital Health, a health tech company focused on value-based care, has secured $31 million in Series B funding, the company announced last week.

A next-generation Vertex Pharmaceuticals pain drug failed to beat a placebo in a Phase 2 clinical trial. Despite the disappointing outcome in bunionectomy pain, the company is continuing ...

Sarepta Therapeutics is still assessing how best to prevent liver injury from its commercialized Duchenne muscular dystrophy gene therapy. But Sarepta partner Hansa Biopharma has encouraging ...

In a new analysis, the American Medical Association detailed the lack of competition among pharmacy benefit managers and ...

In a new action plan, the White House aims to boost the country’s AI innovation through deregulation, infrastructure ...

The Train More Nurses Act would help address these challenges by directing the U.S. Department of Health and Human Services (HHS), as well as the U.S. Labor Department, to conduct a review of ...

More than 75% of patients reported bacterial vaginosis symptom relief at four weeks using Evvy, a recent peer-reviewed study found.

In this episode, we’re joined by Dr. Keith Berkle, chair of Privia Women’s Health, who discusses the challenges OBGYNs face in transitioning to value-based care.

Outdated technology doesn't serve patients or nurses — but by listening to and acting on their concerns we can create innovative new solutions that have the potential to transform healthcare.